Endexx Corp. has outlined key accomplishments over its fiscal fourth quarter ahead of financial reporting, saying it has made significant progress in marketing and distribution following its recent HYLA acquisition to position the company for a strong fiscal 2023.
The developer and distributor of all-natural, plant-derived topical skincare products noted 4Q highlights that included:
- Endexx products are now available in four of the top eight retailers in the US in over 8,000 mass retail stores nationwide;
- Amazon distribution of Blesswell skin care products expanded beyond the US to 13 countries;
- Significant expansion of its international distribution network and potential revenue streams though the controlling interest acquisition of HYLA, a non-nicotine, guarana-based vape product;
- Strengthened the company’s balance sheet by entering into settlement, lock-up and leak-out agreements with its historic investors; and
- HYLA secured two new purchase orders exceeding 200,000 units in the first month of joining Endexx.
READ: Endexx makes Blesswell men's skincare products available internationally through Amazon.com
“The significant events of the fiscal fourth quarter have positioned us to rapidly accelerate our reach within the retail segment for our skin care and pain products by establishing our presence in key retail venues,” Endexx CEO Todd Davis said in a statement.
“This positions us to markedly expand our revenue both through the sales and marketing of HYLA’s unique non-nicotine, guarana-based vape product, which we believe will fill an important and in-demand market niche, as well as providing us with international access to market our other product lines in those regions where HYLA had already established a presence,” Davis added.
Through its operating division CBD Unlimited, Endexx develops and distributes all-natural CBD products derived from cannabis sativa plants containing less than 0.1% THC. Its products include oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief.
Contact Sean at sean@proactiveinvestors.com